JUL 09, 2020 7:46 PM PDT

Fatty acid DGLA kills cancer cells

A study published in Developmental Cell highlights the discovery that a fatty acid called dihomogamma-linolenic acid (DGLA) is capable of killing human cancer cells. This finding has significant implications for future cancer treatment pathways, says corresponding authorJennifer Watts, a Washington State University associate professor. 

The mechanism that Watts and her colleagues discovered involves invoking ferroptosis - otherwise known as iron-dependent cell death - on cancer cells. As the scientists showed in both animal models (the microscopic worm Caenorhabditis elegans) and human cancer cells, DGLA can trigger ferroptosis.

So what is DGLA? You probably haven’t heard of this polyunsaturated fatty acid because it’s not one that we typically consume in our diets, although it is found in small amounts in the human body. But DGLA has been on Watt’s radar for the last two decades. 

"If you could deliver DGLA precisely to a cancer cell, it could promote ferroptosis and lead to tumor cell death," Watts said. "Also, just knowing that this fat promotes ferroptosis might also affect how we think about conditions such as kidney disease and neurodegeneration where we want to prevent this type of cell death."

In this study, the scientists fed the C. elegans a diet of DGLA-laden bacteria. This resulted in all the germ cells in the nematodes dying as well as the stem cells that make the germ cells. First author Marcos Perez explains: 

"Many of the mechanisms we saw in the nematodes were consistent with the hallmarks of ferroptosis in mammalian systems, including the presence of redox-active iron and the inability to repair oxidized lipids, which are like molecular executioners.”

They later showed that DGLA had the same effect on human cancer cells. Watts' team plans to continue exploring this topic in order to determine what makes the nematode germ cells so susceptible to DGLA.

Photo: Pixabay

Sources: Developmental Cell, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUN 22, 2020
Cancer
Methylation Markers That Can be Used to Diagnose Pancreatic Cancer
JUN 22, 2020
Methylation Markers That Can be Used to Diagnose Pancreatic Cancer
Diagnostic tests are the unsung heroes of cancer treatment. While there are more treatments for cancer coming out every ...
JUN 26, 2020
Cancer
Combining Treatments to Improve Acute Myeloid Leukemia Therapy
JUN 26, 2020
Combining Treatments to Improve Acute Myeloid Leukemia Therapy
Acute myeloid leukemia (AML) is a type of blood cancer that prevents the complete maturation of stem cells. These immatu ...
JUN 23, 2020
Cancer
Why are certain people more vulnerable to carcinogens?
JUN 23, 2020
Why are certain people more vulnerable to carcinogens?
A study from the University of Hawaii Cancer Center entitled, "Tumour predisposition and cancer syndromes as models ...
JUN 14, 2020
Technology
Hologram Technology To Ablate Liver Tumors
JUN 14, 2020
Hologram Technology To Ablate Liver Tumors
Augmented reality has been used for clinical studies and data suggests it can be effectively used for liver cancer thera ...
JUL 24, 2020
Cancer
A New Biomarker Candidate for Cancer Diagnostics
JUL 24, 2020
A New Biomarker Candidate for Cancer Diagnostics
One of the best tools in the fight against cancer is diagnostics. In 2018, colorectal cancer was the second most lethal ...
AUG 07, 2020
Cancer
Using organoids to improve chemotherapy for advanced stages of colon and appendiceal cancer
AUG 07, 2020
Using organoids to improve chemotherapy for advanced stages of colon and appendiceal cancer
New research published in the journal Annals of Surgical Oncology uses organoids to finetune chemotherapies that tr ...
Loading Comments...